FDA Alerts
FDA Approves New Breast Cancer Test
The U.S. Food and Drug Administration (FDA) today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin ( trastuzumab ), a commonly used breast cancer treatment.
3-D Trend in Movies Goes Scientific
The FDA today approved the Selenia Dimensions System, the first X-ray mammography device that provides three-dimensional (3-D) images of the breast for breast cancer screening and diagnosis.